tiprankstipranks
Trending News
More News >
Applied DNA Sciences (APDN)
NASDAQ:APDN

Applied DNA Sciences (APDN) Stock Statistics & Valuation Metrics

Compare
956 Followers

Total Valuation

Applied DNA Sciences has a market cap or net worth of $3.03M. The enterprise value is -$2.00M.
Market Cap$3.03M
Enterprise Value-$2.00M

Share Statistics

Applied DNA Sciences has 519,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding519,000
Owned by Insiders1.00%
Owned by Institutions3.43%

Financial Efficiency

Applied DNA Sciences’s return on equity (ROE) is -0.76 and return on invested capital (ROIC) is -130.72%.
Return on Equity (ROE)-0.76
Return on Assets (ROA)-0.55
Return on Invested Capital (ROIC)-130.72%
Return on Capital Employed (ROCE)-1.35
Revenue Per Employee74.60K
Profits Per Employee-154.09K
Employee Count46
Asset Turnover0.27
Inventory Turnover5.51

Valuation Ratios

The current PE Ratio of Applied DNA Sciences is -18.43. Applied DNA Sciences’s PEG ratio is <0.01.
PE Ratio-18.43
PS Ratio0.00
PB Ratio0.12
Price to Fair Value14.09
Price to FCF-0.31
Price to Operating Cash Flow-0.09
PEG Ratio<0.01

Income Statement

In the last 12 months, Applied DNA Sciences had revenue of 3.43M and earned -6.99M in profits. Earnings per share was -1.82.
Revenue3.43M
Gross Profit1.02M
Operating Income-14.02M
Pretax Income-7.09M
Net Income-6.99M
EBITDA-13.33M
Earnings Per Share (EPS)-1.82

Cash Flow

In the last 12 months, operating cash flow was -13.25M and capital expenditures -695.27K, giving a free cash flow of -13.95M billion.
Operating Cash Flow-13.25M
Free Cash Flow-13.95M
Free Cash Flow per Share-26.88

Dividends & Yields

Applied DNA Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta2.59
52-Week Price Change-98.86%
50-Day Moving Average14.85
200-Day Moving Average266.16
Relative Strength Index (RSI)19.72
Average Volume (3m)72.58K

Important Dates

Applied DNA Sciences upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 15, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date

Financial Position

Applied DNA Sciences as a current ratio of 3.36, with Debt / Equity ratio of 4.62%
Current Ratio3.36
Quick Ratio3.17
Debt to Market Cap<0.01
Net Debt to EBITDA0.43
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Applied DNA Sciences has paid 137.30K in taxes.
Income Tax137.30K
Effective Tax Rate-0.02

Enterprise Valuation

Applied DNA Sciences EV to EBITDA ratio is -9.24, with an EV/FCF ratio of -8.72.
EV to Sales35.89
EV to EBITDA-9.24
EV to Free Cash Flow-8.72
EV to Operating Cash Flow-8.98

Balance Sheet

Applied DNA Sciences has $6.82M in cash and marketable securities with $472.39K in debt, giving a net cash position of -$6.35M billion.
Cash & Marketable Securities$6.82M
Total Debt$472.39K
Net Cash-$6.35M
Net Cash Per Share-$12.24
Tangible Book Value Per Share$1.58

Margins

Gross margin is 40.76%, with operating margin of -408.72%, and net profit margin of -203.78%.
Gross Margin40.76%
Operating Margin-408.72%
Pretax Margin-206.57%
Net Profit Margin-203.78%
EBITDA Margin-388.42%
EBIT Margin-408.72%

Analyst Forecast

The average price target for Applied DNA Sciences is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target
Price Target Upside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast-58.46%
EPS Growth Forecast47.98%

Scores

Smart ScoreN/A
AI Score42
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis